Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 15678C102 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
TPG GP A, LLC
13G/A
Amendment 1
|
7.8% |
8/14/2026
Event 6/30/2026
|
|
| TPG GP A, LLC | 7.8% | ||
| Coulter, James G | 7.8% | ||
| Winkelried Jon | 7.8% | ||
|
FMR LLC
13G/A
Amendment 4
|
15.0% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 15.0% | ||
| Abigail P. Johnson | 15.0% | ||
| BlackRock, Inc. 13G | 5.0% |
7/27/2026
Event 6/30/2026
|
|
|
Global Value Investment Portfolio Management Pte Ltd
13G/A
Amendment 1
|
4.2% |
5/14/2026
Event 3/31/2026
|
|
| The Global Value Investment Portfolio Management Pte Ltd | 4.2% | ||
| U.Life Fund | 4.2% | ||
| GVIP Ventures SPC-SP3 | 0% | ||
| Caroline Kwong | 4.2% | ||
| Xingjuan Chao 13G/A Amendment 1 | 4.9% |
5/12/2026
Event 3/31/2026
|
|
|
FMR LLC
13G/A
Amendment 3
|
12.9% |
5/6/2026
Event 3/31/2026
|
|
| FMR LLC | 12.9% | ||
| Abigail P. Johnson | 12.9% | ||
|
FMR LLC
13G/A
Amendment 2
|
10.6% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 10.6% | ||
| Abigail P. Johnson | 10.6% | ||
|
ABG Management Ltd.
13G/A
Amendment 1
|
4.6% |
12/11/2025
Event 12/9/2024
|
|
| ABG WTT-Ceribell Limited | 4.6% | ||
| ABG V-Ceribell Limited | 4.6% | ||
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | 4.6% | ||
| ABG Global Life Science Capital Partners V GP, L.P. | 4.6% | ||
| ABG Global Life Science Capital Partners V GP Limited | 4.6% | ||
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. | 4.6% | ||
| ABG-WTT Global Life Science Capital Partners GP, L.P. | 4.6% | ||
| ABG-WTT Global Life Science Capital Partners GP Limited | 4.6% | ||
| ABG Management Ltd. | 4.6% | ||
| Ally Bridge Group (PE) LLC | 4.6% | ||
| Fan Yu | 4.6% | ||
|
FMR LLC
13G/A
Amendment 1
|
12.2% |
11/5/2025
Event 9/30/2025
|
|
| FMR LLC | 12.2% | ||
| Abigail P. Johnson | 12.2% | ||
|
ABG Management Ltd.
13G
|
6.8% |
5/2/2025
Event 12/31/2024
|
|
| ABG WTT-Ceribell Limited | 6.8% | ||
| ABG V-Ceribell Limited | 6.8% | ||
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | 6.8% | ||
| ABG Global Life Science Capital Partners V GP, L.P. | 6.8% | ||
| ABG Global Life Science Capital Partners V GP Limited | 6.8% | ||
| Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. | 6.8% | ||
| ABG-WTT Global Life Science Capital Partners GP, L.P. | 6.8% | ||
| ABG-WTT Global Life Science Capital Partners GP Limited | 6.8% | ||
| ABG Management Ltd. | 6.8% | ||
| Ally Bridge Group (PE) LLC | 6.8% | ||
| Fan Yu | 6.8% | ||
|
Global Value Investment Portfolio Management Pte Ltd
13G
|
6.6% |
2/20/2025
Event 12/31/2024
|
|
| The Global Value Investment Portfolio Management Pte Ltd | 6.6% | ||
| U.Life Fund | 6.6% | ||
| GVIP Ventures SPC-SP3 | 0.1% | ||
| Caroline Kwong | 6.6% | ||
|
Red Tree GP, LLC
13G
|
6.2% |
2/14/2025
Event 12/31/2024
|
|
| Red Tree GP, LLC | 6.2% | ||
| Red Tree Venture Fund, L.P. | 5.7% | ||
| Red Tree Venture Fund SPV II, LLC | 0.5% | ||
| Heath Lukatch | 6.2% | ||
|
TPG GP A, LLC
13G
|
11.1% |
2/13/2025
Event 12/31/2024
|
|
| TPG GP A, LLC | 11.1% | ||
| James G. Coulter | 11.1% | ||
| Jon Winkelried | 11.1% | ||
| Xingjuan Chao 13G | 5.5% |
2/12/2025
Event 12/31/2024
|
|
| Josef Parvizi 13G | 5.8% |
2/12/2025
Event 12/31/2024
|